abstract |
The present invention relates to 2-piperazin-1-yl-4H-1,3-benzothiazin-4-one derivatives and their use for the treatment of infections in mammals caused by bacteria, especially for example, Tuberculosis (TB), Buruli ulcer and leprosy caused by infection with closely related mycobacteria. |